About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05242848

Integrated Exercise Program in Opioid Agonist Therapy Clinics

Background: Drug use is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. Particular people with opioid dependence have high morbidity and reduced quali...

Lead sponsor: Haukeland University Hospital•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Haukeland University Hospital

Collaborators

Helse Stavanger HF
Helse Vest
University of Bergen

See below each section

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Receiving OAT from an included outpatient clinic with follow-up weekly
•Low level of physical activity measured using IPAQ (assessed at screening)
•Confirming interest in participating in physical activity intervention and providing informed consent (criteria specified)
•Giving informed consent

Exclusion Criteria

•Not able to participate in the intervention due to physical disabilities or severe mental disorders
•Being imprisoned or in inpatient treatment settings

Related studies

Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions

NCT06560866 · Substance-Related Disorders

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

NCT06676059 · Alcoholism, Substance-Related Disorders

Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma

NCT07330349 · Abdominal Injuries, Alcohol Intoxication, and more

RECRUITINGPhase 2

Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder

NCT05886582 · Substance-Related Disorders

RECRUITINGPhase 2

GLP-1R Agonist Treatment for Opioid Use Disorder

NCT06548490 · Opioid Use Disorder, Opioid Abuse and Addiction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 8, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment309

Start dateApr 2022

Last updatedAug 8, 2025

Condition

Substance-Related Disorders

Locations shown

LAR Helse Stavanger HF

Stavanger, Rogaland

Department of Addiction Medicine, Haukeland University Hospital

Bergen, Vestland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 8, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions